🇺🇸 FDA
Patent

US 12023359

Phospholipid compositions for delivery of therapeutic compounds

granted A61KA61K31/12A61K31/122

Quick answer

US patent 12023359 (Phospholipid compositions for delivery of therapeutic compounds) held by Aker BioMarine Human Ingredients AS expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aker BioMarine Human Ingredients AS
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/12, A61K31/122, A61K31/202, A61K31/232